Drug Information

General Information
Drug ID
DR00113
Drug Name
Azathioprine
Synonyms
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine; 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]; 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine; 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine; 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine; 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(Methyl-p-nitro-5-imidazolyl)thiopurine; 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine; 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine; 6-[(1-Methyl-4-nitroimidazol-5-yl)-thio] purine; 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine; A 4638; AI-981/34845012; Azamun; Azamun (TN); Azamun [Czech]; Azanin; Azasan; Azasan (TN); Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine; Azathioprin; Azathioprine (JP15/USP/INN); Azathioprine [USAN:INN:BAN:JAN]; Azathioprine sodium; Azathioprinum; Azathioprinum [INN-Latin]; Azathiopurine; Azatiopr in; Azatioprin; Azatioprina; Azatioprina [INN-Spanish]; Azothioprine; B. W. 57-322; BW 57-322; BW 57322; BW-57-322; Ccucol; Cytostatics; Immuran; Imuran; Imuran (TN); Imurek; Imurel; Imurel (TN); Methylnitroimidazolylmercaptopurine; Muran; Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl); [Methyl(nitroimidazolyl)mercaptopurine]
Drug Type
Small molecular drug
Indication Organ transplant rejection [ICD11: NE84] Approved [1]
Therapeutic Class
Immunosuppressive Agents
Structure
3D MOL 2D MOL
Formula
C9H7N7O2S
Canonical SMILES
CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
InChI
InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)
InChIKey
LMEKQMALGUDUQG-UHFFFAOYSA-N
CAS Number
CAS 446-86-6
Pharmaceutical Properties Molecular Weight 277.27 Topological Polar Surface Area 143
Heavy Atom Count 19 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 7
XLogP
0.1
PubChem CID
2265
PubChem SID
10321142 , 10560483 , 10584680 , 11110740 , 11110741 , 11142069 , 11335761 , 11361000 , 11362878 , 11364839 , 11365440 , 11367401 , 11368002 , 11369963 , 11371476 , 11373003 , 11373785 , 11375563 , 11376164 , 11378131 , 11461972 , 11466122 , 11467242 , 11483991 , 11485723 , 11487884 , 11490124 , 11492058 , 11493878 , 11524329 , 11533962 , 11536345 , 12294767 , 14775167 , 14824335 , 15222101 , 17390031 , 17404591 , 24278074 , 4476272 , 4486208 , 4503338 , 545491 , 7592075 , 7695226 , 7847305 , 7978746 , 8149210 , 8151523 , 9055
ChEBI ID
ChEBI:2948
TTD Drug ID
D07QCE
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Azathioprine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.